Bioventus Statistics Share Statistics Bioventus has 66.36M
shares outstanding. The number of shares has increased by 1.8%
in one year.
Shares Outstanding 66.36M Shares Change (YoY) 1.8% Shares Change (QoQ) 0.3% Owned by Institutions (%) 71.47% Shares Floating 45.42M Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 1.59M, so 2.4% of the outstanding
shares have been sold short.
Short Interest 1.59M Short % of Shares Out 2.4% Short % of Float 6.3% Short Ratio (days to cover) 4.66
Valuation Ratios The PE ratio is -20.46 and the forward
PE ratio is 9.21.
Bioventus's PEG ratio is
0.29.
PE Ratio -20.46 Forward PE 9.21 PS Ratio 1.2 Forward PS 0.8 PB Ratio 4.64 P/FCF Ratio 18.16 PEG Ratio 0.29
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Bioventus.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.31,
with a Debt / Equity ratio of 2.27.
Current Ratio 1.31 Quick Ratio 0.87 Debt / Equity 2.27 Debt / EBITDA -6.77 Debt / FCF 8.88 Interest Coverage -0.31
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $616.43K Profits Per Employee $-36.07K Employee Count 930 Asset Turnover 0.79 Inventory Turnover 2
Taxes Income Tax -5.29M Effective Tax Rate 10.77%
Stock Price Statistics The stock price has increased by -8.47% in the
last 52 weeks. The beta is 0.83, so Bioventus's
price volatility has been higher than the market average.
Beta 0.83 52-Week Price Change -8.47% 50-Day Moving Average 6.65 200-Day Moving Average 9.07 Relative Strength Index (RSI) 55.25 Average Volume (20 Days) 449,659
Income Statement In the last 12 months, Bioventus had revenue of 573.28M
and earned -33.54M
in profits. Earnings per share was -0.75.
Revenue 573.28M Gross Profit 388.23M Operating Income -11.98M Net Income -33.54M EBITDA -49.55M EBIT -10.33M Earnings Per Share (EPS) -0.75
Full Income Statement Balance Sheet The company has 41.58M in cash and 335.63M in
debt, giving a net cash position of -294.05M.
Cash & Cash Equivalents 41.58M Total Debt 335.63M Net Cash -294.05M Retained Earnings -355.08M Total Assets 706.79M Working Capital 89.52M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 38.8M
and capital expenditures -1.01M, giving a free cash flow of 37.79M.
Operating Cash Flow 38.8M Capital Expenditures -1.01M Free Cash Flow 37.79M FCF Per Share 0.58
Full Cash Flow Statement Margins Gross margin is 67.72%, with operating and profit margins of -2.09% and -5.85%.
Gross Margin 67.72% Operating Margin -2.09% Pretax Margin -8.57% Profit Margin -5.85% EBITDA Margin -8.64% EBIT Margin -2.09% FCF Margin 6.59%
